Related Experiment Video
Updated: Jun 7, 2025
Mouse Wound Models and Preparation of Single-Cell Suspensions
Published on: September 27, 2024
Manufacturing exosomes for wound healing: Comparative analysis of culture media
Huy Hoang Dao1,2, Thu-Huyen Nguyen1, Diem Huong Hoang1
1Vinmec Hi-Tech Center, Vinmec Healthcare System, Hanoi, Vietnam.
Abstract:
Mesenchymal stem cell (MSC)-derived exosomes (EXs) have emerged as promising therapeutic agents for wound healing. However, the optimal conditions for manufacturing MSC-derived EXs that maximize their wound-healing potential have yet to be established. Hence, we compared the efficacy of five different MSC culture media, including three different serum-free, a platelet-supplemented, and a fetal bovine serum-supplemented media, in exosome manufacturing for wound healing applications. Although umbilical cord-derived MSCs (UCMSCs) cultured in these media exhibited similar proliferation, morphology, MSC surface marker expression, and stemness, EXs derived from UCMSCs cultured in different culture media displayed varying levels of growth factors and cytokines. Notably, EXs derived from platelet-supplemented media (DM-PLT_EXs) exhibited significantly higher concentrations of keratinocyte growth factor (KGF), vascular endothelial growth factor (VEGF-A), platelet-derived growth factor (PDGF-BB), interleukin 6 (IL-6), interleukin 7 (IL-7), and interleukin 8 (IL-8) than EXs from other media. These differences correlated with the superior capability of DM-PLT_EXs to promote human skin fibroblast proliferation and stimulate angiogenesis of human umbilical vein endothelial cells, making them a more suitable choice for wound healing applications. Our findings emphasize the significance of the culture medium selection in tailoring the therapeutic potential of UCMSC-derived EXs for wound healing.
Insights
Selecting the right culture medium is crucial for manufacturing mesenchymal stem cell (MSC)-derived exosomes (EXs) for wound healing. Platelet-supplemented media yielded EXs with higher therapeutic potential, promoting fibroblast proliferation and angiogenesis.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Cell Biology
Background:
- Mesenchymal stem cell (MSC)-derived exosomes (EXs) show promise for wound healing.
- Optimal manufacturing conditions for therapeutic EXs are not well-defined.
- Culture medium significantly impacts exosome composition and function.
Purpose of the Study:
- To compare the efficacy of different culture media for manufacturing MSC-derived EXs for wound healing.
- To identify the culture medium that maximizes the wound-healing potential of EXs.
- To investigate the impact of culture media on exosome content and biological activity.
Main Methods:
- Cultured umbilical cord-derived MSCs (UCMSCs) in five different media: three serum-free, one platelet-supplemented, and one fetal bovine serum-supplemented.
- Analyzed exosome content, including growth factors and cytokines.
- Assessed the biological activity of EXs on human skin fibroblasts and human umbilical vein endothelial cells.
Main Results:
- UCMSCs cultured in different media showed similar proliferation, morphology, and stemness.
- EXs derived from platelet-supplemented media (DM-PLT_EXs) had higher concentrations of KGF, VEGF-A, PDGF-BB, IL-6, IL-7, and IL-8.
- DM-PLT_EXs demonstrated superior promotion of fibroblast proliferation and angiogenesis.
Conclusions:
- Culture medium selection is critical for tailoring the therapeutic potential of UCMSC-derived EXs.
- Platelet-supplemented media enhance the wound-healing capabilities of EXs.
- DM-PLT_EXs are a promising candidate for advanced wound healing therapies.
